In breast cancer cell lines, the insulin-sensitive glucose transporter 12 (SLC2A12) protein levels are increased with E2 [126], suggesting a regulatory effect of estradiol on glucose metabolism. This evidence concerns the gene SLC2A12 and breast cancer.